A case of primary hypertrophic osteoarthropathy: Management considerations
暂无分享,去创建一个
[1] Hengyan Zhang,et al. Successful treatment of pachydermoperiostosis patients with etoricoxib, aescin, and arthroscopic synovectomy , 2017, Medicine.
[2] M. Burnett,et al. Hypertrophic osteoarthropathy presenting as unilateral cellulitis with successful treatment using pamidronate disodium. , 2012, The Journal of clinical and aesthetic dermatology.
[3] M. Tekin,et al. Homozygous mutations in the 15-hydroxyprostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy , 2009, Rheumatology International.
[4] D. Bonthron,et al. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy , 2008, Nature Genetics.
[5] K. Kinoshita,et al. A case of pachydermoperiostosis treated by oral administration of a bisphosphonate and arthroscopic synovectomy , 2007, Modern rheumatology.
[6] Tomoko Matsumoto,et al. A case of pachydermoperiostosis associated with arthritis , 2003, Modern Rheumatology.
[7] A. Cotten,et al. Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. , 2000, The Journal of rheumatology.
[8] F. Nicklason,et al. The use of pamidronate in hypertrophic pulmonary osteoarthropathy (HPOA). , 1997, Australian and New Zealand journal of medicine.